Get more replies from employers
Send a job-specific resume in minutes.
BigHat Biosciences is seeking a Machine Learning Engineer to advance ML-driven antibody design. You will build generative models for antibody sequences and structures, and create multi-objective optimization methods for rapid lab-in-the-loop validation.
Join a fast-paced, interdisciplinary team applying state-of-the-art ML to accelerate therapeutics development, with collaboration across data science, biology, and automation in San Mateo, CA.
Department: DS/ML (Data Science/Machine Learning)
Employment Type: Full Time
Location: San Mateo, CA
The role: We are seeking a creative, ambitious Machine Learning Scientist or Engineer to advance the state of the art in ML-driven therapeutic antibody design.
At BigHat Biosciences our full-stack antibody drug development platform uses AI/ML to drive every stage from discovery to optimization. Our roboticized high-throughput wet-lab continually adds to our large proprietary datasets, which are piped through a custom LIMS++ data management and orchestration layer to automatically update and deploy the latest models. This makes development of complex, net-gen therapeutics ‘trivially parallelizable’, at a pace which only accelerates as we develop better ML tooling.
You’re not interested in just git-cloning the latest NeurIPS pub and swapping out the dataset. Motivated by an enthusiasm for the possibility of addressing unmet patient need, and a curiosity about the underlying biology, you’ll apply your top-tier ML skillset to refine and expand this state of the art protein engineering platform. Success will mean not only hands-on methods development, but actively participating in the application of our platform to the accelerated design of new drugs for devastating diseases.
The salary estimated for this position is $150,000 - $200,000 + bonus + options + benefits. Compensation will vary depending on job-related knowledge, skills, and experience. Actual compensation will be confirmed in writing at the time of the offer.